• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Creative Medical Technology Holdings Inc (NQ: CELZ )

    4.020 -0.120 (-2.90%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 50,884
    Open 4.110
    Bid (Size) 3.800 (2)
    Ask (Size) 4.110 (1)
    Prev. Close 4.140
    Today's Range 3.950 - 4.192
    52wk Range 2.650 - 10.28
    Shares Outstanding 1,338,126
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Are Pharma Stocks Harmful To Your Financial Health ?
    It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label. 
    Via Talk Markets

    Performance

    YTD
    -12.62%
    -12.62%
    1 Month
    +38.14%
    +38.14%
    3 Month
    +30.88%
    +30.88%
    6 Month
    -9.87%
    -9.87%
    1 Year
    -13.55%
    -13.55%

    More News

    Read More
    CELZ Stock Earnings: Creative Medical Tech Misses EPS for Q2 2024
    Via InvestorPlace
    CELZ Stock Earnings: Creative Medical Tech Beats EPS for Q1 2024
    Via InvestorPlace
    Creative Medical Technology Holdings Provides Corporate Update
    From Creative Medical Technology Holdings, Inc.
    Via Business Wire
    What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?
    Via ACCESSWIRE
    Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
    Via AB Newswire
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
    From Creative Medical Technology Holdings, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
    From Creative Medical Technology Holdings, Inc.
    Via Business Wire
    Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
    Via ACCESSWIRE
    Creative Medical Technology Holdings (NASDAQ: CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem™ For Addressing Chronic Lower Back Pain
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.